Literature DB >> 24155122

Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes.

Charles H Lawrie1, Erika Larrea, Gorka Larrinaga, Ibai Goicoechea, María Arestin, Marta Fernandez-Mercado, Ondrej Hes, Francisco Cáceres, Lorea Manterola, José I López.   

Abstract

Clear cell tubulopapillary renal cell carcinoma (CCPRCC) is a recently described rare renal malignancy that displays characteristic gross, microscopic and immunohistochemical differences from other renal tumour types. However, CCPRCC remains a very poorly understood entity. We therefore sought to elucidate some of the molecular mechanisms involved in this neoplasm by carrying out targeted next-generation sequencing (NGS) to identify associated mutations, and in addition examined the expression of non-coding (nc) RNAs. We identified multiple somatic mutations in CCPRCC cases, including a recurrent [3/14 cases (21%)] non-synonymous T992I mutation in the MET proto-oncogene, a gene associated with epithelial-to-mesenchymal transition (EMT). Using a microarray approach, we found that the expression of mature (n = 1105) and pre-miRNAs (n = 1105), as well as snoRNA and scaRNAs (n = 2214), in CCPRCC cases differed from that of clear cell renal cell carcinoma (CCRCC) or papillary renal cell carcinoma (PRCC) tumours. Surprisingly, and unlike other renal tumour subtypes, we found that all five members of the miR-200 family were over-expressed in CCPRCC cases. As these miRNAs are intimately involved with EMT, we stained CCPRCC cases for E-cadherin, vimentin and β-catenin and found that the tumour cells of all cases were positive for all three markers, a combination rarely reported in other renal tumours that could have diagnostic implications. Taken together with the mutational analysis, these data suggest that EMT in CCPRCC tumour cells is incomplete or blocked, consistent with the indolent clinical course typical of this malignancy. In summary, as well as describing a novel pathological mechanism in renal carcinomas, this study adds to the mounting evidence that CCPRCC should be formally considered a distinct entity. Microarray data have been deposited in the GEO database [GEO accession number (GSE51554)].
Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  EMT; clear cell papillary renal cell carcinoma; miRNA; non-coding RNA; renal carcinoma

Mesh:

Substances:

Year:  2014        PMID: 24155122     DOI: 10.1002/path.4296

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  20 in total

1.  Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma.

Authors:  Karl-Friedrich Deml; Hans-Ulrich Schildhaus; Eva Compérat; Adriana von Teichman; Martina Storz; Peter Schraml; Joseph V Bonventre; Falko Fend; Barbara Fleige; Andreas Nerlich; Helmut E Gabbert; Nikolaus GaBler; Rainer Grobholz; Seife Hailemariam; Raoul Hinze; Ruth Knüchel; Benoit Lhermitte; Gabriella Nesi; Thomas Rüdiger; Guido Sauter; Holger Moch
Journal:  Am J Surg Pathol       Date:  2015-07       Impact factor: 6.394

Review 2.  The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome.

Authors:  Francesco Massari; Chiara Ciccarese; Ondrej Hes; Michal Michal; Anna Caliò; Michelangelo Fiorentino; Francesca Giunchi; Alessandro D'Amuri; Francesca Sanguedolce; Roberto Sabbatini; Annalisa Guida; Andrea Ardizzoni; Camillo Porta; Roberto Iacovelli; Giampaolo Tortora; Luca Cima; Cinzia Ortega; Alberto Lapini; Guido Martignoni; Matteo Brunelli
Journal:  Pathol Oncol Res       Date:  2017-07-10       Impact factor: 3.201

Review 3.  Clear cell papillary renal cell carcinoma: a review.

Authors:  Naoto Kuroda; Chisato Ohe; Fumi Kawakami; Shuji Mikami; Mitsuko Furuya; Keiko Matsuura; Masatsugu Moriyama; Yoji Nagashima; Ming Zhou; Fredrik Petersson; José I López; Ondrej Hes; Michal Michal; Mahul B Amin
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 4.  DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.

Authors:  Javier C Angulo; Jose I López; Santiago Ropero
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

Review 5.  Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas.

Authors:  Qiu Rao; Qiu-Yuan Xia; Liang Cheng; Xiao-Jun Zhou
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

6.  Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.

Authors:  Enrico Munari; Luigi Marchionni; Apurva Chitre; Masamichi Hayashi; Guido Martignoni; Matteo Brunelli; Stefano Gobbo; Pedram Argani; Mohamad Allaf; Mohammad O Hoque; George J Netto
Journal:  Hum Pathol       Date:  2014-01-31       Impact factor: 3.466

Review 7.  The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments.

Authors:  Javier C Angulo; Claudia Manini; Jose I López; Angel Pueyo; Begoña Colás; Santiago Ropero
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

8.  The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management.

Authors:  Stanley Weng; Renzo G DiNatale; Andrew Silagy; Roy Mano; Kyrollis Attalla; Mahyar Kashani; Kate Weiss; Nicole E Benfante; Andrew G Winer; Jonathan A Coleman; Victor E Reuter; Paul Russo; Ed Reznik; Satish K Tickoo; A Ari Hakimi
Journal:  Eur Urol       Date:  2020-10-10       Impact factor: 20.096

9.  MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential.

Authors:  Marta Fernandez-Mercado; Lorea Manterola; Charles H Lawrie
Journal:  Curr Genomics       Date:  2015-10       Impact factor: 2.236

10.  Snail heterogeneity in clear cell renal cell carcinoma.

Authors:  Laura Zaldumbide; Asier Erramuzpe; Rosa Guarch; Rafael Pulido; Jesús M Cortés; José I López
Journal:  BMC Cancer       Date:  2016-03-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.